HRTX - Opportunities in the Rapidly Growing Pain Management Sector

“No pain, no gain” is a motivational gym saying used for years. Investors have found the saying also applies to portfolio gains. The pain management industry is rapidly growing and now provides an even broader spectrum of publicly traded opportunities. Why? Reduced opioid use has opened a path for inventive new therapeutics to become the new go-to where an opiod would have been prescribed previously. Estimates on the potential for the industry were just released in a report by Zion Market Research. The report demonstrates the pain management therapeutics industry is expected to amass earnings of about $81.9 billion by 2026. This is an increase of $16.3 billion over 2019 earnings. Read More >>